Johnson & Johnson

All News Archive

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 39 Next >

	European Agency for the Evaluation of Medicinal Products Recommends Suspension of Marketing Authorisation for IONSYS® November 20, 2008
	Ortho Biotech Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer November 20, 2008
	Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 November 20, 2008
	Tibotec Begins Enrollment in Europe for Phase III Trial of Telaprevir in HCV Patients who Failed Prior Treatment November 20, 2008
	Magnetically Steered Irrigated Tip Cardiac Catheter for Treatment of Irregular Heart Rhythms Now Available Throughout the European Union November 18, 2008
	Long-Term TITAN Study Evaluates PREZISTA®/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults November 18, 2008

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 39 Next >

This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2009. All Rights Reserved.